Phase 2 Eczema Trial, Recruiting NCT07330934 Sponsor: Innovent Biologics (Suzhou) Co. Ltd. Condition: Eczema
Back to Eczema

Phase 2 Eczema Trial, Recruiting

NCT07330934
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are able to understand and agree to the study terms by signing a consent form
  • You are 18 years old or older, of any gender
  • You have been diagnosed with atopic dermatitis (eczema) for at least 1 year, using recognised medical criteria
  • Your eczema is currently moderate-to-severe, based on specific measures of rash severity, how much of your body is affected (10% or more), and itch levels (confirm with trial site for exact score details)
  • Your eczema has not responded well enough to creams or ointments, or those treatments are not suitable for you for medical reasons

Who may not be able to join:

  • You have certain other health conditions that could affect your safety or the study results, such as conditions affecting the heart, lungs, digestive system, kidneys, blood, or mental health
  • You have a history of active or suspected tuberculosis, or any signs of it on a chest scan or other tests
  • You have a known or suspected infection with parasitic worms or other parasites
  • You have a history of cancer, unless it was a specific type of skin cancer that was fully removed or successfully treated (confirm with trial site)
  • You have a history of a severe allergic reaction to a drug or a life-threatening allergic reaction (anaphylaxis)
  • You faint at the sight of blood, have a strong fear of blood, or cannot cope with having blood taken
  • You are pregnant, breastfeeding, or have a positive pregnancy test at the time of screening
  • You have previously received an organ transplant or a stem cell transplant
  • You test positive for certain infections at screening, including hepatitis B, hepatitis C, syphilis, or HIV
  • You have received certain specific treatments within a set period of time before the study begins (confirm with trial site for exact details)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 0512-69566088

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Innovent Biologics (Suzhou) Co. Ltd.
Registry
ClinicalTrials.gov
Start date
31 December 2025
Est. completion
30 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Percent change from baseline in Eczema Area and Severity Index (EASI) score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov